Report Detail
Global Iruplinac Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4707955 |
- 17 June, 2026 |
- Global |
- 72 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Iruplinac Tablets market size was valued at US$ 17.70 million in 2025 and is forecast to a readjusted size of US$ 59.38 million by 2032 with a CAGR of 8.7% during review period.
Iruplinalkib is a new-generation selective RET tyrosine kinase inhibitor independently developed in China. Targeting RET fusions and RET mutations, it is mainly applied in the clinical treatment of locally advanced or metastatic non-small cell lung cancer, medullary thyroid carcinoma and other malignant tumors with positive RET fusion after prior treatment. By specifically inhibiting the abnormal activation of the RET kinase signaling pathway, the drug blocks the proliferation, invasion and metastasis of tumor cells. Featuring high target selectivity, favorable safety and independent domestic innovation advantages, it optimizes the precise treatment regimens for tumors with RET alterations. Currently included in the national medical insurance catalog, it is widely used in clinical oncology treatment across China.In 2025, global Iruplinalkib production reached approximately 107,000 bottles.
As a highly selective RET inhibitor independently developed in China, Iruplinalkib boasts significant market competitiveness in the treatment of RET fusion-positive tumors. Driven by the 持续 rising demand for precision medicine, expanding national medical insurance coverage and growing clinical recognition in China, its market penetration has advanced steadily. Compared with imported drugs of the same class, Iruplinalkib holds a key position in indications such as advanced non-small cell lung cancer and medullary thyroid carcinoma, supported by clinical data better tailored to Chinese patients, favorable safety and accessibility advantages. While competition in the RET targeted therapy space is intensifying, the product continues to consolidate its clinical and market position through differentiated efficacy and domestic innovation attributes. It is expected to further unlock growth potential via indication expansion, channel penetration and overseas market layout in the future.
This report is a detailed and comprehensive analysis for global Iruplinac Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Iruplinac Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Iruplinac Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Iruplinac Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Iruplinac Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Iruplinac Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Iruplinac Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Iruplinac Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
30 mg / tablet
60 mg / tablet
Market segment by Combination Therapy
Iruplinalkib Combined With Cabozantinib
Iruplinalkib Combined With Pralsetinib
Market segment by Sales Channel
Hospital
Retail
Online
Market segment by Application
Non-Small Cell Lung Cancer
Medullary Thyroid Carcinoma
Differentiated Thyroid Carcinoma
Others
Major players covered
Qilu Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Iruplinac Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Iruplinac Tablets, with price, sales quantity, revenue, and global market share of Iruplinac Tablets from 2021 to 2026.
Chapter 3, the Iruplinac Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Iruplinac Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Iruplinac Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Iruplinac Tablets.
Chapter 14 and 15, to describe Iruplinac Tablets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Iruplinac Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 30 mg / tablet
- 1.3.3 60 mg / tablet
- 1.4 Market Analysis by Combination Therapy
- 1.4.1 Overview: Global Iruplinac Tablets Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
- 1.4.2 Iruplinalkib Combined With Cabozantinib
- 1.4.3 Iruplinalkib Combined With Pralsetinib
- 1.5 Market Analysis by Sales Channel
- 1.5.1 Overview: Global Iruplinac Tablets Consumption Value by Sales Channel: 2021 Versus 2025 Versus 2032
- 1.5.2 Hospital
- 1.5.3 Retail
- 1.5.4 Online
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Iruplinac Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Non-Small Cell Lung Cancer
- 1.6.3 Medullary Thyroid Carcinoma
- 1.6.4 Differentiated Thyroid Carcinoma
- 1.6.5 Others
- 1.7 Global Iruplinac Tablets Market Size & Forecast
- 1.7.1 Global Iruplinac Tablets Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Iruplinac Tablets Sales Quantity (2021-2032)
- 1.7.3 Global Iruplinac Tablets Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Qilu Pharmaceutical
- 2.1.1 Qilu Pharmaceutical Details
- 2.1.2 Qilu Pharmaceutical Major Business
- 2.1.3 Qilu Pharmaceutical Iruplinac Tablets Product and Services
- 2.1.4 Qilu Pharmaceutical Iruplinac Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Qilu Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Iruplinac Tablets by Manufacturer
- 3.1 Global Iruplinac Tablets Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Iruplinac Tablets Revenue by Manufacturer (2021-2026)
- 3.3 Global Iruplinac Tablets Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Iruplinac Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Iruplinac Tablets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Iruplinac Tablets Manufacturer Market Share in 2025
- 3.5 Iruplinac Tablets Market: Overall Company Footprint Analysis
- 3.5.1 Iruplinac Tablets Market: Region Footprint
- 3.5.2 Iruplinac Tablets Market: Company Product Type Footprint
- 3.5.3 Iruplinac Tablets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Iruplinac Tablets Market Size by Region
- 4.1.1 Global Iruplinac Tablets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Iruplinac Tablets Consumption Value by Region (2021-2032)
- 4.1.3 Global Iruplinac Tablets Average Price by Region (2021-2032)
- 4.2 North America Iruplinac Tablets Consumption Value (2021-2032)
- 4.3 Europe Iruplinac Tablets Consumption Value (2021-2032)
- 4.4 Asia-Pacific Iruplinac Tablets Consumption Value (2021-2032)
- 4.5 South America Iruplinac Tablets Consumption Value (2021-2032)
- 4.6 Middle East & Africa Iruplinac Tablets Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Iruplinac Tablets Sales Quantity by Type (2021-2032)
- 5.2 Global Iruplinac Tablets Consumption Value by Type (2021-2032)
- 5.3 Global Iruplinac Tablets Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Iruplinac Tablets Sales Quantity by Application (2021-2032)
- 6.2 Global Iruplinac Tablets Consumption Value by Application (2021-2032)
- 6.3 Global Iruplinac Tablets Average Price by Application (2021-2032)
7 North America
- 7.1 North America Iruplinac Tablets Sales Quantity by Type (2021-2032)
- 7.2 North America Iruplinac Tablets Sales Quantity by Application (2021-2032)
- 7.3 North America Iruplinac Tablets Market Size by Country
- 7.3.1 North America Iruplinac Tablets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Iruplinac Tablets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Iruplinac Tablets Sales Quantity by Type (2021-2032)
- 8.2 Europe Iruplinac Tablets Sales Quantity by Application (2021-2032)
- 8.3 Europe Iruplinac Tablets Market Size by Country
- 8.3.1 Europe Iruplinac Tablets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Iruplinac Tablets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Iruplinac Tablets Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Iruplinac Tablets Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Iruplinac Tablets Market Size by Region
- 9.3.1 Asia-Pacific Iruplinac Tablets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Iruplinac Tablets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Iruplinac Tablets Sales Quantity by Type (2021-2032)
- 10.2 South America Iruplinac Tablets Sales Quantity by Application (2021-2032)
- 10.3 South America Iruplinac Tablets Market Size by Country
- 10.3.1 South America Iruplinac Tablets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Iruplinac Tablets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Iruplinac Tablets Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Iruplinac Tablets Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Iruplinac Tablets Market Size by Country
- 11.3.1 Middle East & Africa Iruplinac Tablets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Iruplinac Tablets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Iruplinac Tablets Market Drivers
- 12.2 Iruplinac Tablets Market Restraints
- 12.3 Iruplinac Tablets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Iruplinac Tablets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Iruplinac Tablets
- 13.3 Iruplinac Tablets Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Iruplinac Tablets Typical Distributors
- 14.3 Iruplinac Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Iruplinac Tablets. Industry analysis & Market Report on Iruplinac Tablets is a syndicated market report, published as Global Iruplinac Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Iruplinac Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
